<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3-pharmaceutics-10-00247" class="ref">
 <label class="label">3.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Perioli</surname>
    <given-names class="given-names">L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ambrogi</surname>
    <given-names class="given-names">V.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Nauta</surname>
    <given-names class="given-names">L.D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Nocchetti</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rossi</surname>
    <given-names class="given-names">C.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Effects of hydrotalcite-like nanostructured compounds on biopharmaceutical properties and release of BCS class II drugs: The case of flurbiprofen</article-title>
  <source class="source">Appl. Clay Sci.</source>
  <year class="year">2011</year>
  <volume class="volume">51</volume>
  <fpage class="fpage">407</fpage>
  <lpage class="lpage">413</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.clay.2010.12.019</pub-id>
 </element-citation>
</ref>
